| 证券代码：603058 | 证券简称：永吉股份 | 公告编号：2025-091 | | --- | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | | 贵州永吉印务股份有限公司 第六届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 （一）本次会议的召开符合《中华人民共和国公司法》（以下简称"《公司 法》"）等有关法律法规及《贵州永吉印务股份有限公司章程》的有关规定。 （二）贵州永吉印务股份有限公司（以下简称"公司"）于2025年10月14 日以书面、电话、微信等方式向公司全体董事发出董事会通知。 （三）公司第六届董事会第十四次会议于2025年10月24日在公司会议室以 现场结合线上通讯方式召开。 表决结果：董事会以7票同意、0票反对、0票弃权审议通过了本议案。 1 具体内容请查阅公司同日在指定信息披露媒体上海证券交易所网站 （www.sse.com.cn）披露的公司《2025年第三季度报告》。 （四）会议由公司董事长召集并主持。会议应到董事 ...

贵州永吉印务股份有限公司 2025 年第三季度报告 证券代码：603058 证券简称：永吉股份 转债代码：113646 转债简称：永吉转债 贵州永吉印务股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 249,685,803.45 | 9.64 | 677,490,405.74 | ...

Group 1 - The core point of the article is that Yongji Co., Ltd. reported a revenue of 250 million yuan in the third quarter, representing a year-on-year increase of 9.64% while net profit decreased by 15.53% to 42.17 million yuan [1] - For the first three quarters, the company achieved a revenue of 677 million yuan, which is an 11.06% year-on-year growth, but net profit fell by 22.94% to 98.78 million yuan [1]

Core Insights - Yongji Co., a leading tobacco label company in Guizhou, has faced significant challenges in its capital operations, including two failed capital increases and two unsuccessful cross-industry acquisitions within two years [1][4]. Financial Performance - In the first half of 2025, the company achieved a revenue of 428 million yuan, representing a year-on-year increase of 11.91%, but the net profit attributable to shareholders dropped to 56.61 million yuan, a decrease of 27.67% [2]. - The company's net profit after deducting non-recurring gains and losses fell by 41.12% year-on-year, indicating a more severe decline in the profitability of its core business [3]. Strategic Challenges - Yongji Co. has been actively seeking transformation due to sluggish growth in its main business. In 2020, the company invested in the Australian controlled drug (medical cannabis) sector to cultivate a second main business [3]. - The company attempted to enter the semiconductor field by acquiring a 51% stake in Shanghai Aiyuan Semiconductor for 107 million yuan in 2021, but this investment has underperformed, with cumulative losses exceeding 34 million yuan from 2022 to 2024 [3]. - In August 2025, the company planned to acquire the chip company Tenafei, but the plan was terminated just two weeks later, highlighting the difficulties traditional companies face during transformation [4].

Core Viewpoint - Yongji Co., Ltd. has decided to terminate its plan for a specific issuance of A-shares for the year 2025 due to changes in the capital market environment and the company's actual situation and development plans [1] Group 1: Termination of Share Issuance - Yongji Co., Ltd. held meetings on October 9, 2025, where the decision to terminate the specific issuance of A-shares was approved [1] - The company had been actively promoting the issuance since its announcement but ultimately decided to terminate it after careful analysis and communication with relevant parties [1] Group 2: Previous Issuance Plan - The planned issuance aimed to raise a total of no more than 490.50 million yuan, which was intended for acquiring 100% equity of Phytoca Holdings Pty Ltd, constructing a research and design center, and repaying bank loans [1] - The shares were to be issued to no more than 35 specific investors, with a minimum price set at 80% of the average trading price over the previous 20 trading days [2][3] Group 3: Shareholder Structure - As of the announcement date, the total share capital of the company was 419,884,997 shares, with the controlling shareholder holding 34.20% of the shares [4] - The maximum number of shares to be issued was capped at 125,965,499 shares, ensuring that the controlling interest would remain unchanged post-issuance [4]

Core Viewpoint - Yongji Co., Ltd. has decided to terminate its plan to issue A-shares to specific investors for the year 2025 due to changes in the capital market environment and the company's actual situation and development plans [1][2] Group 1: Termination of Fundraising Plans - The company announced the termination of the A-share issuance plan after more than six months since it was initially approved on March 12, 2023 [1] - In 2023, Yongji Co. also terminated a previously planned fundraising of 830 million yuan [2][7] - The termination will not adversely affect the company's normal operations or the interests of shareholders, especially minority shareholders [2] Group 2: Fundraising Details - The initial fundraising plan aimed to raise approximately 490 million yuan, which was intended for acquiring 100% of Phytoca Holdings Pty Ltd, constructing a research and design center, and repaying bank loans [2][3] - The total investment for the acquisition of Phytoca was approximately 282 million yuan, with the company planning to use around 620 million Australian dollars (approximately 286 million yuan) for the acquisition [3][4] Group 3: Financial Performance and Market Context - As of September 30, 2024, Phytoca reported total assets of approximately 14.23 million Australian dollars and a net asset of about 1.37 million Australian dollars [6] - Yongji Co. has experienced a slowdown in growth, with a revenue increase of 10.69% to 905 million yuan and a net profit increase of 59.77% to 160 million yuan in 2024, compared to much higher growth rates in 2023 [7]

Core Viewpoint - The company has decided to terminate its plan for a specific issuance of A-shares for the year 2025 due to changes in the capital market environment and its own development plans [1] Group 1 - The company has been actively promoting the issuance plan since its announcement [1] - The decision to terminate the issuance was made after careful analysis and communication with relevant parties [1] - The termination is influenced by various factors, including the current market conditions and the company's actual situation [1]

Core Viewpoint - Yongji Co., Ltd. has decided to terminate its plan for a specific issuance of A-shares for the year 2025 due to changes in the capital market environment and the company's actual situation and development plans [1] Group 1 - The company has been actively promoting the relevant work since the announcement of the specific issuance plan [1] - The decision was made after careful analysis and full communication and discussion with relevant parties [1] - The termination is influenced by various factors, including the current capital market environment [1]

证券代码：603058 证券简称：永吉股份 公告编号：2025-090 转债代码：113646 转债简称：永吉转债 贵州永吉印务股份有限公司 可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 未转股可转债情况：截至2025年9月30日，尚未转股的"永吉转债"金额 为人民币137,422,000.00元，占可转债发行总量的94.2098%。 ● 本季度转股情况：自2025年7月1日至2025年9月30日，共有6,000.00元 "永吉转债"转换成公司股票，本期因转股形成的股份数量为739股。 一、可转债发行上市概况 经中国证券监督管理委员会证监许可[2021]2509号文核准，贵州永吉印务股 份有限公司（以下简称"公司"）于2022年4月14日公开发行了1,458,680张可转 换公司债券，每张面值100元，发行总额14,586.80万元。本次发行的可转债票面 利率为第一年0.30%、第二年0.50%、第三年1.00%、第四年1.50%、第五年1.80%、 第六年2.50%；期限为 ...

| 证券代码：603058 | 证券简称：永吉股份 | 公告编号：2025-089 | | --- | --- | --- | | 转债代码：113646 | 转债简称：永吉转债 | | 贵州永吉印务股份有限公司 关于终止2025年度向特定对象发行A股股票 事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 贵州永吉印务股份有限公司（以下简称"公司"）于2025年10月9日召开第 六届董事会第十三次会议和第六届监事会第九次会议，审议通过了《关于终止 2025年度向特定对象发行A股股票事项的议案》，同意公司终止2025年度向特定 对象发行A股股票（以下简称"本次向特定对象发行股票"）事项，现将具体情 况公告如下： 一、公司本次向特定对象发行股票的基本情况 1、2025年3月12日，公司召开第六届董事会第九次会议和第六届监事会第五 次会议，审议通过《关于公司向特定对象发行股票方案的议案》等相关议案。 二、终止本次向特定对象发行股票事项的原因 公司自本次向特定对象发行股票方案公布以来，一直积极推进相关工作，但 考虑目前资本市 ...